MATINAS BIOPHARMA HOLDINGS, INC. Increase (Decrease) in Other Accrued Liabilities
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Increase (Decrease) in Other Accrued Liabilities of -$483.93 thousand for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2015-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2015-06-30 was -$450.58K, a 289.13% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2015-03-31 was -$33.35K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2014-06-30 was $238.24K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2014-03-31 was -$75.72K.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 6 month |
|---|---|---|
| 2015-06-30 | -$450.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$483.93K 10-Q · filed 2015-08-13 |
| 2015-03-31 | -$33.35K 10-Q · filed 2015-05-15 | |
| 2014-06-30 | $238.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $162.52K 10-Q · filed 2015-08-13 |
| 2014-03-31 | -$75.72K 10-Q · filed 2015-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |